Kallidinogenase
- Generic Name
- Kallidinogenase
- Drug Type
- Biotech
- CAS Number
- 9001-01-8
- Unique Ingredient Identifier
- OT9M1PSK9N
- Indication
适用于治疗轻至中度急性血栓性脑梗死。
The Study to Reevaluate the Safety and Efficacy of Human Urinary Kallikrein
- First Posted Date
- 2015-09-29
- Last Posted Date
- 2018-01-17
- Lead Sponsor
- Techpool Bio-Pharma Co., Ltd.
- Target Recruit Count
- 2186
- Registration Number
- NCT02562183
- Locations
- 🇨🇳
Chenzhou NO.1 People's Hospital, Chenzhou, Hunan, China
🇨🇳Harrison International Peace Hospital, Hengshui, Hebei, China
🇨🇳NO.2 Hospital XiaMen, Xiamen, Fujian, China
Multi-modality MRI Study on Effect to Collateral Circulation and Blood Perfusion of Acute Cerebral Infarction by Human Urinary Kallidinogenase
Phase 2
Completed
- Conditions
- Cerebral Infarction
- Interventions
- First Posted Date
- 2014-10-08
- Last Posted Date
- 2014-10-08
- Lead Sponsor
- XuanwuH 2
- Target Recruit Count
- 120
- Registration Number
- NCT02259738
- Locations
- 🇨🇳
Department of Neurolgy,Xuanwu Hospital of Capital Medical University, Beijing, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath